Japan· JP-4490019F4027
エバスチン
A ebastine product containing エバスチン, registered in Japan by 住友ファーマ, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Ebastine is registered in 13 of 19 countries.
Countries holding a registration under ATC R06AX22 (ebastine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 8 of them publish a price we can compare per daily dose
Ebastine · ATC R06AX22
13 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
Price per daily dose
What a daily dose of ebastine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.15 in France to $0.27 in Italy — a ×1.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ebastine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- IT Italy$0.27
- FR France$0.15
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- エバスチン
- Manufacturer
- 住友ファーマ
- Country
- Japan (JP)
- ATC code
- R06AX22
- ATC class
- Ebastine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R06AX22
Ebastine, as other registers publish it.
- ItalyCLEVERALMIRALL S.A.
- GermanyEbastelAlmirall, S.A.
- DenmarkEbastin "Brown"Brown & Burk IR Limited
- DenmarkEbastin "Brown"Brown & Burk IR Limited
- SwedenEbastin 2care4 20 mg Filmdragerad tablett2care4 ApS
- SwedenEbastin Abacus Medicine 10 mg Filmdragerad tablettAbacus Medicine A/S
- SwedenEbastin ABECE 10 mg Munsönderfallande tablettEvolan Pharma AB
- SwedenEbastin Apofri 10 mg Munsönderfallande tablettEvolan Pharma AB
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb207b9a-ec46-4d75-b07a-7d2592e2d57c GET /v1/drugs/eb207b9a-ec46-4d75-b07a-7d2592e2d57c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０ｍｇ１錠",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "4490019F4027",
"category": "内用薬",
"price_yen": 30.6,
"generic_name": "エバスチン",
"product_name_jp": null,
"therapeutic_class": "4490",
"transitional_expiry": null
}See everything about ebastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.